Reported Standalone quarterly numbers for Norris Medicines are:Net Sales at Rs 1.21 crore in March 2023 up 48.05% from Rs. 0.82 crore in March 2022.
Quarterly Net Loss at Rs. 0.54 crore in March 2023 up 75.65% from Rs. 2.23 crore in March 2022.
EBITDA stands at Rs. 0.56 crore in March 2023 up 236.59% from Rs. 0.41 crore in March 2022.
Norris Medicine shares closed at 11.86 on May 25, 2023 (BSE) and has given -14.06% returns over the last 6 months and -40.85% over the last 12 months.
| Norris Medicines | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'23 | Dec'22 | Mar'22 | | Net Sales/Income from operations | 1.21 | 3.16 | 0.82 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 1.21 | 3.16 | 0.82 | | EXPENDITURE | | Consumption of Raw Materials | -0.38 | 1.08 | 0.50 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | 0.16 | 0.55 | -0.07 | | Power & Fuel | -- | -- | -- | | Employees Cost | 0.61 | 0.65 | 0.52 | | Depreciation | 0.18 | 0.15 | 0.66 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 0.27 | 0.55 | 0.30 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 0.37 | 0.18 | -1.09 | | Other Income | 0.01 | 0.00 | 0.01 | | P/L Before Int., Excpt. Items & Tax | 0.38 | 0.19 | -1.07 | | Interest | 0.37 | 0.39 | 0.08 | | P/L Before Exceptional Items & Tax | 0.01 | -0.20 | -1.15 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 0.01 | -0.20 | -1.15 | | Tax | 0.56 | -- | 1.08 | | P/L After Tax from Ordinary Activities | -0.54 | -0.20 | -2.23 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -0.54 | -0.20 | -2.23 | | Equity Share Capital | 9.93 | 9.93 | 9.93 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.54 | -0.20 | -2.23 | | Diluted EPS | -0.54 | -0.20 | -2.23 | | EPS After Extra Ordinary | | Basic EPS | -0.54 | -0.20 | -2.23 | | Diluted EPS | -0.54 | -0.20 | -2.23 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
